Fundraising FoxDiverse Biotech
Orlando, US · Founded 2017 · Florida corporation
Find your way into Diverse Biotech
Sign up to see every warm intro you have to Diverse Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diverse Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diverse Biotech develops novel synthetic cannabinoid compounds and drug conjugate therapies aimed at cancer treatment. The company operates in the pharmaceutical and biotech sector with a focus on oncology therapeutics.
Founders & leadership
Diverse Biotech was founded in 2017 by William Fisher.
WF
PA
Philip ArlenChief Scientific OfficerPhilip Arlen holds a PhD in Microbiology, Immunology, and Molecular Genetics from UCLA and has held leadership roles in clinical research at the University of Miami's Sylvester Comprehensive Cancer Center, as well as prior positions at Sanford Burnham Prebys and Revolution Medicine before becoming Chief Scientific Officer at Diverse Biotech.
PH
Paul HershbergerChief Chemist
JP
John PatrickExecutive Vice President & Chief Medical Officer
SV
STELLA VNOOKNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1M disclosed across 2 of 3 rounds · 2018–2023
▶$950KofferedMar 2023 · PharmaceuticalsRule 506(b)
▶$950KofferedMar 2023 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JOHN PATRICKDirector
- Phillip HaretosDirector
- WILLIAM FISHERExecutive Officer, Director, Promoter
- PHILIP ARLENDirector
- Phyllis FenneyDirector
- Offering amount
- $950K
- Minimum investment
- $100K
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$337.9KraisedSep 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$337.9KraisedSep 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- WILLIAM FISHERExecutive Officer, Director, Promoter
- STELLA VNOOKExecutive Officer, Director, Promoter
- Offering amount
- $9M
- Amount sold
- $337.9K
- Minimum investment
- $50K
- First sale
- Mar 2019
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$669KraisedJun 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$669KraisedJun 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- BEAUDON SPAULDINGExecutive Officer, Director, Promoter
- WILLIAM FISHERExecutive Officer, Director, Promoter
- Offering amount
- $7.5M
- Amount sold
- $669K
- Minimum investment
- $50K
- First sale
- Jun 2018
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Diverse Biotech do?
- Diverse Biotech develops novel synthetic cannabinoid compounds and drug conjugate therapies aimed at cancer treatment. The company operates in the pharmaceutical and biotech sector with a focus on oncology therapeutics.
- Who founded Diverse Biotech?
- Diverse Biotech was founded by William Fisher in 2017.
- How much funding has Diverse Biotech raised?
- Diverse Biotech has disclosed $1M raised across 2 of its 3 known rounds.
- Where is Diverse Biotech headquartered?
- Diverse Biotech is headquartered in Orlando, US.